BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10640590)

  • 21. Percutaneous absorption of non-steroidal anti-inflammatory drugs from in situ gelling xyloglucan formulations in rats.
    Takahashi A; Suzuki S; Kawasaki N; Kubo W; Miyazaki S; Loebenberg R; Bachynsky J; Attwood D
    Int J Pharm; 2002 Oct; 246(1-2):179-86. PubMed ID: 12270620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transdermal delivery of ketoprofen using microemulsions.
    Rhee YS; Choi JG; Park ES; Chi SC
    Int J Pharm; 2001 Oct; 228(1-2):161-70. PubMed ID: 11576778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formulation development, in vitro and in vivo evaluation of microemulsion-based gel loaded with ketoprofen.
    Nikumbh KV; Sevankar SG; Patil MP
    Drug Deliv; 2015; 22(4):509-15. PubMed ID: 24266589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparative in vitro and in vivo studies on the permeation and penetration of ketoprofen and ibuprofen in human skin].
    Bock U; Krause W; Otto J; Haltner E
    Arzneimittelforschung; 2004; 54(9):522-9. PubMed ID: 15500198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nano-proniosomes enhancing the transdermal delivery of mefenamic acid.
    Wen MM; Farid RM; Kassem AA
    J Liposome Res; 2014 Dec; 24(4):280-9. PubMed ID: 24779560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional characterisation of novel analgesic product based on self-regulating drug carriers.
    Cevc G; Vierl U; Mazgareanu S
    Int J Pharm; 2008 Aug; 360(1-2):18-28. PubMed ID: 18524509
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro release and antiinflammatory activity of topical formulations of ketoprofen.
    Moretti MD; Gavini E; Peana AT
    Boll Chim Farm; 2000; 139(2):67-72. PubMed ID: 10920531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of preparation technique on the properties of liposomes encapsulating ketoprofen-cyclodextrin complexes aimed for transdermal delivery.
    Maestrelli F; González-Rodríguez ML; Rabasco AM; Mura P
    Int J Pharm; 2006 Apr; 312(1-2):53-60. PubMed ID: 16469460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Permeation enhancement of ketoprofen using a supersaturated system with antinucleant polymers.
    Kumprakob U; Kawakami J; Adachi I
    Biol Pharm Bull; 2005 Sep; 28(9):1684-8. PubMed ID: 16141540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of percutaneous permeation of flurbiprofen and ketoprofen after application of transdermal patches using a lateral sectioning approach in hairless rats.
    Goi N; Morishita K; Taniguchi A; Ishii T; Saitoh K
    Pharm Dev Technol; 2010 Dec; 15(6):658-65. PubMed ID: 20883157
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of ketoprofen loaded proliposomal powders for improved gastric absorption and gastric tolerance: in vitro and in situ evaluation.
    Gangishetty H; Eedara BB; Bandari S
    Pharm Dev Technol; 2015; 20(6):641-51. PubMed ID: 24820852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ketoprofen Microemulsion for Improved Skin Delivery and In Vivo Anti-inflammatory Effect.
    Aliberti ALM; de Queiroz AC; Praça FSG; Eloy JO; Bentley MVLB; Medina WSG
    AAPS PharmSciTech; 2017 Oct; 18(7):2783-2791. PubMed ID: 28374340
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An insight on human skin penetration of diflunisal: lipogel versus hydrogel microemulsion.
    Sallam MA; Motawaa AM; Mortada SM
    Drug Dev Ind Pharm; 2015 Jan; 41(1):141-7. PubMed ID: 24171693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel transdermal drug penetration enhancer: synthesis and enhancing effect of alkyldisiloxane compounds containing glucopyranosyl group.
    Akimoto T; Nagase Y
    J Control Release; 2003 Mar; 88(2):243-52. PubMed ID: 12628331
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transdermal permeation of novel n-acetyl-glucosamine/NSAIDs mutual prodrugs.
    Israel B; Garner ST; Thakare M; Elder D; Abney T; Azadi P; Beach JW; Price JC; Ahmed H; Capomacchia AC
    Pharm Dev Technol; 2012; 17(1):48-54. PubMed ID: 20858066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Percutaneous absorption of ketoprofen. I. In vitro release and percutaneous absorption of ketoprofen from different ointment bases.
    Gürol Z; Hekimoğlu S; Demirdamar R; Sumnu M
    Pharm Acta Helv; 1996 Aug; 71(3):205-12. PubMed ID: 8818309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relative bioavailability of ketoprofen 20% in a poloxamer-lecithin organogel.
    Dowling TC; Arjomand M; Lin ET; Allen LV; McPherson ML
    Am J Health Syst Pharm; 2004 Dec; 61(23):2541-4. PubMed ID: 15595229
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involvement of Endocytosis in the Transdermal Penetration Mechanism of Ketoprofen Nanoparticles.
    Nagai N; Ogata F; Ishii M; Fukuoka Y; Otake H; Nakazawa Y; Kawasaki N
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30041452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The in vitro delivery of NSAIDs across skin was in proportion to the delivery of essential fatty acids in the vehicle--evidence that solutes permeate skin associated with their solvation cages?
    Heard CM; Gallagher SJ; Harwood J; Maguire PB
    Int J Pharm; 2003 Aug; 261(1-2):165-9. PubMed ID: 12878406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amphiphilic star-like macromolecules as novel carriers for topical delivery of nonsteroidal anti-inflammatory drugs.
    Djordjevic J; Michniak B; Uhrich KE
    AAPS PharmSci; 2003 Oct; 5(4):E26. PubMed ID: 15198514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.